FDA Import Refusal 799-9603810-5/11/1 — SATO PHARMACEUTICAL CO.,LTD.

SATO PHARMACEUTICAL CO.,LTD. — FEI 3015481594

The FDA refused shipment 799-9603810-5/11/1 from SATO PHARMACEUTICAL CO.,LTD. (Japan) on March 8, 2024. The refused product falls under Drugs and Biologics — NAPHAZOLINE HCL (ADRENERGIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 8, 2024
Country
Japan
Product Category
Drugs and Biologics
Product Code
60CAV46 NAPHAZOLINE HCL (ADRENERGIC)
Charges
75